MPG peptides, Pβ

O=C(N1[C@@H](CCC1)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@H](C(O)=O)C(C)C)=O)=O)=O)=O)=O)=O)[C@H](CCC(N)=O)NC([C@H](CO)NC([C@@H](NC([C@H](C)NC(CNC([C@H](CCSC)NC([C@H]([C@H](O)C)NC([C@H](CO)NC(CNC([C@H](C)NC([C@H](C)NC(CNC([C@H](CC(C)C)NC([C@@H](NC(CNC([C@H](CC(C)C)NC([C@@H](NC([C@H](CC(C)C)NC([C@H](C)NC(CN)=O)=O)=O)CC2=CC=CC=C2)=O)=O)=O)CC3=CC=CC=C3)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC4=CNC5=CC=CC=C45)=O)=O

[1]Davoodi S, et al. Design and in vitro delivery of HIV-1 multi-epitope DNA and peptide constructs using novel cell-penetrating peptides. Biotechnol Lett. 2019 Nov;41 (11) :1283-1298.|[2]Zhang XX, et al. Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates. J Control Release. 2012 Apr 10;159 (1) :2-13.